Actavis recalls flurandrenolide tape; Recipharm lines up deal; India explores boosting API production;

> Actavis is recalling 78,522 cartons of flurandrenolide tape used to treat inflammation and itching due to certain skin conditions because it may not meet potency specifications. Notice

> Sweden's Recipharm has a letter of intent with LIDDS that it would handle the scale-up, manufacture and quality assurance of LIDDS' pharmaceutical products. Report

> Apotex is recalling 33,795 bottles of bromfenac ophthalmic solution because the excipient was not retested at the appropriate date. Notice

> The Indian government is considering recommendations on how to support API manufacturing in the country. Report

Suggested Articles

Novavax has inked a $60 million contract with the U.S. Department of Defense to help fund U.S.-based manufacturing of its COVID-19 vaccine candidate.

Vaccine maker Inovio has accused a longtime manufacturing partner of hampering its efforts to produce 1 million doses of a potential COVID-19 vaccine.

Roche's global manufacturing leader Pierre-Alain Ruffieux will take the reins and oversee the Moderna COVID-19 vaccine collaboration.